Frontiers in Molecular Medicine Seminar

Ellen Sidransky, M.D., will present a seminar as part of the Frontiers in Molecular Medicine lecture series on Thursday, July 27, 2017 at 4:00 pm in the Education Union Auditorium. Dr. Sidransky's research focuses on the biology and genetics of both Gaucher disease, a rare, recessively inherited disorder with highly variable symptoms, and Parkinson's disease, a common complex disorder.

TDP-43 in Neurodegenerative Diseases

Yuna Ayala, Ph.D., published a paper in The Journal of Biological Chemistry detailing studies on TAR DNA-ginding Protein 43 (TDP-43) and its role in neurodegenerative diseases, such as amytrophic lateral sclerosis (ALS). More

NEJM Editorial

Paul Hauptman, M.D., published an editorial in the New England Journal of Medicine reviewing the results of the Trail of Ularitide Efficacy and Safety in Acute Heart Failure (TRUE-AHF) study. More

PRF Cycle 14 Awardees Announced

The RPC has announced the recipients of the President's Research Fund awards for the 2017 Cycle 14 applications. More

Exercise in a Pill

Thomas Burris, Ph.D., and John Walker, Ph.D., received grants from the Department of Defense and the NIH to study how two nuclear signaling receptors, REV-ERB and ERR, are involved in muscle metabolism. More

Bird Flu Vaccine Study

Sharon Frey, M.D., will head a Phase 1 clinical trial funded by the NIH, which will be conducted at SLU and five other vaccine centers. More

Regulation of LDL Cholesterol

Thomas Burris, Ph.D., published a paper in Biochemical Pharmacology on studies of the nuclear receptor, REV-ERB, and its role in regulation of LDL cholesterol. More

Biomarkers for Pain

Daniela Salvemini, Ph.D., received a grant from The Mayday Fund to determine if either of two key molecules, S1PR1 and A3AR, are biomarkers of chronic pain. Her lab team will work with SLUCare clinicians on the study. More

Dendritic Cell Symphony

Daniel Hawiger, M.D., Ph.D., published a paper in Immunity reporting recent research on special immune system cells, dendritic cells, which direct other lymphocytes in the immune system what to do and how to do it. More

New Vaccine for Chagas Disease

Daniel Hoft, M.D., Ph.D., recently published a paper in PLoS Pathogens detailing findings on Th17 cells, a subset of white blood cells that provide significant protection against Trypanosoma cruzi, the protozoan parasite that causes Chagas disease. More

Gemini Computing Cluster

The Department of Biochemistry maintains a state-of-the-art, high performance computing cluster that can be used for GPU computing, advanced molecular analyses, and rapid macromolecular conformation sampling. More

About

The RPC is the advisory body to the Dean of the School of Medicine about policies, activities, and long-term objectives pertaining to research in the School of Medicine.

Members are appointed by the Dean to a 3-year term, with the recommendations of the Committee on Faculty Affairs.

Activities of the RPC include:

Review of nominations for awards and fellowships
Reviews of Research Centers and Cores
Review of major equipment requisitions
Administration of Internal Study Section
Administration of Presidential Research Fund

To read the latest news and events at Saint Louis University, please visit the Newslink website.

The School of Medicine Master Calendar contains information on Seminars, Grand Rounds, Journal Clubs, and other presentations in all Medical Center departments.